Consumers need not panic due to Pfizer’s inability to supply Depo Testosterone. By Rubin van Niekerk
The current shortage of Pfizer’s Depo Testosterone can easily be solved by Fagron, established in Rotterdam in 1990, which has grown into one of the world’s fastest growing compounding pharmaceutical groups. There are branches in Cape Town, Johannesburg, and Pretoria, as well over 300 branched around the world. Unfortunately, many doctors globally, are unaware of the benefits offered by innovative compounding pharmaceutical groups, that can take years off people’s biological clocks at competitive rates. Due to the compounding nature of pharmaceutical products, the development time is usually two to three days. They produce Testosterone Cypionate which is like Depo Testosterone at a similar cost. Both use an oil-soluble 17 (beta)-cyclopentylpropionate ester of the androgenic hormone testosterone.
Various cutting edge individualised products that are not available in pharmacies are produced by compounding pharmacies. Sometimes they produce medicine that is not available due to unforeseen circumstances in big pharma. Some patients have suffered adverse medical effects due to Pfizer’s inability to supply sufficient stock since September 2021. An informed GP should also be able to guide patients to an alternative product that may even be superior to Pfizer’s product. The risk profile varies from product to product and from person to person, so professional guidance is highly recommended.
If they are unable to guide you, then maybe consult an endocrinologist or urologist. Dr Cobus van Niekerk has many gay patients and understands the hormonal impact on aging. He mentions that there are many other products available like Nebido, which is quite expensive, but lasts 6 to 12 weeks and Sustanon, otherwise compounding pharmacies are quite useful. Understandably many doctors tend to be wary of overly enthusiastic patients who love consulting the Oracle way too much on complex medical questions.